Center-Authored Papers

Filters: Keyword is Menopause  [Clear All Filters]
B
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
Bray PF, Larson JC, LaCroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD et al..  2008.  Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events.. The American journal of cardiology. 101(11):1599-1605. Abstract
Brock K, Huang W-Y, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R, Peters U, Ahn J, Purdue M, Mason RS et al..  2010.  Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women.. The Journal of steroid biochemistry and molecular biology. 121(1-2):462-6. Abstract
Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH.  1998.  Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 16(5):1689-96. Abstract
Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, Lane D, Ockene J, Woods NF, Yasmeen S et al..  2010.  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.. Menopause (New York, N.Y.). 17(5):946-54. Abstract
C
Crandall CJ, Aragaki A, Cauley JA, Manson JE, Leblanc E, Wallace R, Wactawski-Wende J, Lacroix A, O'Sullivan MJ, Vitolins M et al..  2015.  Associations of menopausal vasomotor symptoms with fracture incidence.. The Journal of clinical endocrinology and metabolism. 100(2):524-34. Abstract
D
Dodin S, Cunnane SC, Masse B, Lemay A, Jacques H, Asselin G, Tremblay-Mercier J, Marc I, Lamarche B, Légaré F et al..  2008.  Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.. Nutrition (Burbank, Los Angeles County, Calif.). 24(1):23-30. Abstract
F
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
G
Goodwin WJ, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS.  2008.  Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(10):1650-6. Abstract
H
Hoffman M, Molpus K, Roberts WS, Lyman GH, Cavanagh D.  1990.  Tuboovarian abscess in postmenopausal women.. The Journal of reproductive medicine. 35(5):525-8. Abstract
Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI.  2011.  Relationship between menopausal symptoms and risk of postmenopausal breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(2):379-88. Abstract
K
Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE.  2010.  Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study.. Cancer epidemiology. 34(1):34-9. Abstract
Kabat GC, Kim M, Adams-Campbell LL, Caan BJ, Chlebowski RT, Neuhouser ML, Shikany JM, Rohan TE.  2009.  Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women.. The American journal of clinical nutrition. 90(1):162-9. Abstract
Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV.  1995.  Timing of weight gain and breast cancer risk.. Cancer. 76(2):243-9. Abstract
L
Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR.  2008.  Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):43-50. Abstract
M
Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Orav JE, Willett WC, Egan KM.  2009.  Meat consumption, heterocyclic amines, NAT2, and the risk of breast cancer.. Nutrition and cancer. 61(1):36-46. Abstract
P
Peterson LM, Kurland BF, Link JM, Schubert EK, Stekhova S, Linden HM, Mankoff DA.  2011.  Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.. Nuclear medicine and biology. 38(7):969-78. Abstract
Phipps AI, Ichikawa L, Bowles EJA, Carney PA, Kerlikowske K, Miglioretti DL, Buist DSM.  2010.  Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates.. Maturitas. 67(1):60-6. Abstract
Phipps AI, Chlebowski RT, Prentice RL, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M et al..  2011.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.. Journal of the National Cancer Institute. 103(6):470-7. Abstract
Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H et al..  2010.  Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract
Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM.  2008.  Statin use and risk of breast cancer.. Cancer. 112(1):27-33. Abstract
Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN et al..  2010.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.. Cancer causes & control : CCC. 21(6):839-46. Abstract
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
R
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.  2011.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.  2008.  Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.. Menopause (New York, N.Y.). 15(1):51-8. Abstract